
AHF & Transplant Fellow @ClevelandClinic. Proudest achievement = being Dada.
Houston, TX
Joined March 2020
- Tweets72
- Following115
- Followers192
- Likes254
Brian Hsi, MD retweeted
Often we get a consult for RHC on AHF pt and elevated HCO3 + diuretic resistance with believe pt must be intravasc dry, but we find MAP, RAP, PCWP well elevated. Not intravascular dry but proximal nephron NaHCO3 retention is the cause of the diuretic resistance @RyanTedfordMD
Brian Hsi, MD retweeted
Replying to @HFSA
Make sure @RanLeeMD and @AndrewHigginsMD are involved if the intersection of critical care and AHFTC is on the table! They are leaders in these fields and they speak for many of us!
Brian Hsi, MD retweeted
Check it out!!! We just published international donor heart selection guidelines. Special thanks to Dr Shelley Hall and Dr Hannah Copeland.
"Unable to get MRI due to AICD"
MRI can be safely performed even in pts w/ legacy MRI-nonconditional CIEDs. There's even data on MRI in pts w/ abandoned leads👇
CIEDs ≠ MRI contraindication. Spread the word and narrow the gap!
@HeartToProve @HMH_IMres #MedEd #CardioTwitter
Details into the life of an advanced HF patient @jilliannec! Sharing so hopefully more colleagues can get a glimpse of what our patients really go through. Thankful for our patients, their #hardtokill willpower💪, and allowing us to work with them.
@dranulala
I would honestly say the same thing. My LVAD (Vlad) was the best thing that could have happened to me. Literally changed my life.
I wrote about it right after my surgery here:
heartfailuretoharvard.com/20…
#heartfailure #itsaboutlife #heartlife #cardiotwitter #transplanttwitter
2
Dr. Guha's key tips for pulmonary HTN:
▶️PH = mPAP > 20 mmHg (new definition!)
▶️RHC is key in diagnosis!
▶️Initiate dual therapy for PAH up front!
▶️Always think about CTEPH (potentially curable!)
Learn more👉 https://nitter.cf/t.co/uX76A8PBAK
#cardiotwitter #MedEd #MedTwitter
A great overview of device therapies in HF by my favorite big sis @mahwash_kassi!
For each therapy, patient selection is key! Come learn more👉 https://nitter.cf/t.co/uX76A8PBAK
#cardiotwitter #MedEd #MedTwitter
Tips from @RayanYousefzai on HFrEF Rx at #CNC2021:
▶️Do not need to trial ACEi/ARB first before using ARNI
▶️SGLT2i improves mortality and HF hospitalization and protects kidney fxn!
▶️Updated 2021 Rx guidelines 👇
Learn more👉 https://nitter.cf/t.co/uX76A8PBAK
#cardiotwitter #MedEd
The Great N. Kleiman on antiplatelet Rx:
▶️ASA✅2° prevention, ⏫CACS;❌1° prevention.
▶️Prematurely d/c DAPT highest risk factor for stent thrombosis!
▶️Shortened ASA duration may be helpful after PCI.
Learn more👉 https://nitter.cf/t.co/uX76A8PBAK
#cardiotwitter #MedEd #MedTwitter
Dr. Ross Reul giving a great overview of CABG
▶️In appropriately selected patients, CABG can provide complete revascularization and is safe
▶️Appropriate Rx before procedure👉improved outcomes
Learn more👉 https://nitter.cf/t.co/uX76A8PBAK
#cardiotwitter #MedEd #MedTwitter
Going on now! Come watch @athakkarMD teach radiation safety to save yourselves from one of the many possible reasons for midcareer headaches! And while in the cath lab anyway, listen to @IceTeaMD so you don't miss RV failure...
#Cardiotwitter #MedEd #ACCFIT #AHAFIT @HMethodistCV
Live in 1H! Join us for this week's #GrandRounds Conference featuring @athakkarMD and @IceTeaMD! @HMethodistCV #MedEd #CardioEd #CardioTwitter
Watch it Live @ https://nitter.cf/t.co/9Kwuzd3vy4
Brian Hsi, MD retweeted
Check out our combined @HMethodistCV & @ClevelandClinic amyloid cardiogenic shock experience - IABP viable bridging strategy for CA to OHT or VAD @VarinderKaurRa1 @JerryEstepMD @bhtrachtenberg @HMHCardioFellow #ACC21
Brian Hsi, MD retweeted
New #ACC21 SimPub in @JACCJournals from #TRANSLATEHF collab led by @RBPatelMD
Strong risk-treatment paradox in HF & kidney disease, such that pts with the highest mortality are treated with ↓ disease-modifying Rx
Supported by @AHAScience & @AstraZeneca
jacc.org/doi/10.1016/j.jacc.…
ELI5: Previously, high dose ASA🩸> low dose. ADAPTABLE, ~40% crossover from high to low dose, conclusion = no difference in🩸... Now even some experts are saying "choose whatever dose you'd like"🤔Wrong message? Would love to hear opinions (and🙏explain)!
#ACC21 #CardioTwitter
0%High dose may be better
0%U can do whatever u like
100%Less is more
3 votes • Final results 1
👀Ready for that board question on arrhythmias in Chagas disease?👀 Come listen @ 10 CST to TX ACC @MiguelVldrbno, @scfuentesr, @aalahmadmd, @KTamirisaMD, @JavierSanchezMD and get that extra point in Oct! 👉https://nitter.cf/t.co/ufIo2Kx2Zr
#ACCFIT #AHAFIT #CardioTwitter @HMethodistCV
Brian Hsi, MD retweeted
1/ Ready for a #Tweetorial on coronary artery calcium (CAC) score?
Keep reading to:
☢️Understand the pathophysiology of coronary artery calcium
☢ Identify the utility of the CAC score
☢️Recognize the limitations of CAC scoring
Normal BNP ≠ no HF! Most studies of BNP have focused on diagnosing HFrEF, but ~1/3 of HFpEF pts may have normal BNP (<100) 👉 BNP-deficient phenogroup. BNP should not be used to rule out HFpEF!
https://nitter.cf/t.co/zuXNujg5SM
#HFpEF #MedEd #CardioTwitter @HFpEF
4
MRAs, ARNI, SGLT2i, interatrial shunt, GSN ablation, and more - Rx options becoming available now / may come in future. But phenotyping and pt selection is most key in HFpEF!
"New Approaches to HFpEF in the Era of Precision Medicine"👉https://nitter.cf/t.co/WchOkvyzvi @HFpEF @HMethodistCV
2
Power of Sotagliflozin:
SCORED: 🔽CV death, HF🏥, acute HF episodes in DM + eGFR 25-60.
SOLOIST-WHF: 🔽CV death, HF🏥, urgent visits in DM + HF🏥 (all EFs?!?)➡️also good in HFpEF?
More about the SGLT2i magic 👉 https://nitter.cf/t.co/qaSXIJ0c8M #ACCEL @JamesCFangMD @gabrielsteg





























